Results 231 to 240 of about 2,938,349 (358)
Activity cliff-aware reinforcement learning for de novo drug design. [PDF]
J CheminformHu X, Liu G, Zhao Y, Zhang H.
europepmc +1 more source
A Primer of Deuterium in Drug Design [PDF]
Future Medicinal Chemistry, 2019 Cargnin S., Serafini M., Pirali T.
openaire +5 more sources
Editorial: Machine learning in computer-aided drug design. [PDF]
Front Mol BiosciPerišić O, Sevim Bayrak C, Gunady MK.
europepmc +1 more source
Understanding and Overcoming Immunotherapy Resistance in Skin Cancer: Mechanisms and Strategies
Aging and Cancer, EarlyView.This narrative review explores the mechanisms driving immunotherapy resistance in skin cancer, including tumor microenvironment factors, genetic mutations, and immune evasion strategies. It highlights potential strategies to overcome resistance, offering insights for improving therapeutic outcomes and guiding future research in personalized ...
Shreya Singh Beniwal +8 more
wiley +1 more source
Recent advances from computer-aided drug design to artificial intelligence drug design. [PDF]
RSC Med ChemWang K, Huang Y, Wang Y, You Q, Wang L.
europepmc +1 more source
Re-engineering of Human Urokinase Provides a System for Structure-based Drug Design at High Resolution and Reveals a Novel Structural Subsite [PDF]
, 2000 V. Nienaber +3 more
openalex +1 more source
Treatment of chronic wounds: time for immunologic concern on drug design? [PDF]
, 2010 Hazrati, S.M., Kalavi, K.
core +1 more source
Aging and Cancer, EarlyView.Aging weakens the blood–brain barrier (BBB), increasing susceptibility to CNS cancers and complicating treatment. This review examines BBB deterioration, its impact on drug delivery, and potential interventions like targeting neuroinflammation and advanced therapies.
Quang La, Aiman Baloch, David F. Lo
wiley +1 more source
CoDNet: controlled diffusion network for structure-based drug design. [PDF]
Bioinform AdvKazi Md F +8 more
europepmc +1 more source